This funding will support the expansion of AINU’s hospital network from seven to 20 locations, with a focus on Tier 2 cities such as Patna, Bhubaneshwar, and Coimbatore.

Asia Healthcare Holdings (AHH), backed by Singapore’s GIC and TPG, has announced an investment of INR 400 crore in the Asian Institute of Nephrology and Urology (AINU) over the next four to five years.

This funding will support the expansion of AINU’s hospital network from seven to 20 locations, focusing on Tier 2 cities such as Patna, Bhubaneshwar, and Coimbatore.

Currently, AINU operates seven hospitals, including two in metropolitan cities, Hyderabad and Chennai, and five in Tier 2 locations like Vizag and Siliguri. The flagship centre in Hyderabad has a 150-bed capacity, Chennai has 100 beds, while other Tier 2 centres typically have 75 beds each.

Vishal Bali, Executive Chairman of AHH, outlined the investment plan, stating, “INR 600 crore of our capital is in AINU, and there is another INR 400 crore outlay between now and FY30. That means we will invest INR 1,000 crore in this specialty. We will invest the fund in creating a bigger footprint for AINU.”

He added, “We see a big opportunity at AHH in creating and exponentially growing single specialty enterprises in Tier 2 cities.”

The new investment will increase AHH’s total capital in AINU to INR 1,000 crore since FY24, marking it as one of the most significant single-specialty investments in the urology and nephrology segment.

For the fiscal year 2026-27, AHH has earmarked INR 150 crore to open 3 to 4 additional urology and nephrology hospitals.

AINU’s CEO, Sandeep Guduru, highlighted the focus on enhancing clinical services, including robotic surgery programs, stating, “We are looking to ramp up the clinical capabilities and services in each of these hospitals. Robotic programmes are an important service that we have. Currently, we have two centres offering this service, and we want to start ramping it up in other centres.” He also mentioned the new centre in Banjara Hills, Hyderabad, where subspecialities such as female urology and paediatric urology are being developed.

According to investment bank Avendus, the single-specialty hospital market in India is expected to more than double from $15 billion to $31 billion in the next three to four years, driven mainly by private equity-led expansion in smaller towns and hinterlands. The share of single-specialty hospitals is projected to rise to 40% of the total healthcare market by 2028, up from 30%.

On the sector’s growth prospects, Bali said, “There are certain specialties that have come out of the multispecialty format and created a growth trajectory of their own.” He added, “We are gung-ho about single specialty as it allows us to scale quickly, our return on capital employed (ROCE) is much higher than what the multispecialty institutions see. From an Indian context, this format will work well because of a replication opportunity.”

Stay tuned for more such updates on Digital Health News